Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 206.00
Bid: 202.00
Ask: 210.00
Change: -1.00 (-0.48%)
Spread: 8.00 (3.96%)
Open: 206.00
High: 206.00
Low: 206.00
Prev. Close: 207.00
FRAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Franchise Brands PLC

24 Feb 2022 07:00

RNS Number : 6329C
Franchise Brands PLC
24 February 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Franchise Brands plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

n/a

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Franchise Brands plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

23/02/22

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 0.5p each in Franchise Brands plc

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

 

TOTAL:

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

n/a

Details, including nature of the rights concerned and relevant percentages:

n/a

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Beneficial holdings of the Directors of Franchise Brands plc (including their close relatives and the related trusts of either of them) in Franchise Brands plc ordinary shares of 0.5p each

Name

Number of ordinary shares held

% of voting share capital

Stephen Hemsley¹

 

23,302,996

24.31

Nigel Wray²

22,366,303

23.33

David Poutney³

3,710,365

3.87

Rob Bellhouse

111,260

0.12

Chris Dent⁴

61,602

0.06

Tim Harris5

1,385,365

1.45

Peter Molloy6

77,342

0.08

Julia Choudhury7

1,546,701

1.61

Colin Rees

 

403,009

0.42

Total

52,964,943

55.25

 

 

¹ Total holdings of Stephen Hemsley and close family members/trusts (of which 1,123,152 Franchise Brands Shares are non-beneficial interests held by close relatives)

² Total holdings of Nigel Wray and close family members/trusts (of which 223,880 Franchise Brands Shares are non-beneficial interests held by a trust)

³ Total holdings of David Poutney and close family members/trusts (of which 13,870 Franchise Brands Shares are non-beneficial interests held by close relatives)

⁴ Total holdings of Chris Dent and close family members/trusts

5 Total holdings of Tim Harris and close family members/trusts

6 Total holdings of Peter Molloy and close family members/trusts (of which 5,386 Franchise Brands Shares are non-beneficial interests held by close relatives)

7 Total holdings of Julia Choudhury and close family members/trusts

 

(b) Rights to subscribe for ordinary shares of 0.5p each in Franchise Brands plc

 

Details of options held by Directors and any close relatives

 

Name

Maximum number outstanding

Scheme

Exercise price (£)

Date of grant

Expiry Date

 

Julia Choudhury

71,970

 

 

34,091

2016 EMI Scheme

 

2020 CSOP Scheme

 

0.690

 

 

0.88

11/12/2018

 

 

15/09/2020

11/12/2028

 

 

15/09/2030

Chris Dent

303,030

 

 

21,970

 

 

34,091

 

 

17,045

 

2016 EMI Scheme

 

2016 EMI Scheme

 

2020 CSOP Scheme

 

2020 MSO Scheme

 

0.495

 

 

0.690

 

 

0.88

 

 

0.05

12/12/2017

 

 

11/12/2018

 

 

15/09/2020

 

 

15/09/2020

12/12/2027

 

 

11/12/2028

 

 

15/09/2030

 

 

15/09/2030

Tim Harris

71,970

 

 

34,091

 

2016 EMI Scheme

 

2020 MSO Scheme

 

0.690

 

 

0.88

11/12/2018

 

 

15/09/2020

11/12/2028

 

 

15/09/2030

Peter Molloy

150,000

 

153,030

 

106,000

 

34,091

 

28,409

2016 EMI Scheme

 

2016 EMI Scheme

 

2016 EMI Scheme

 

2020 CSOP Scheme

 

2020 MSO Scheme

 

0.670

 

 

0.495

 

 

0.690

 

 

0.88

 

 

0.05

11/04/2017

 

 

12/12/2017

 

 

11/12/2018

 

 

15/09/2020

 

 

15/09/2020

11/04/2027

 

 

12/12/2027

 

 

11/12/2028

 

 

15/09/2030

 

 

15/09/2030

Colin Rees

303,030

 

 

71,970

 

 

34,091

 

 

39,773

 

2016 EMI Scheme

 

2016 EMI Scheme

 

2020 CSOP Scheme

 

2020 MSO Scheme

 

0.495

 

 

0.690

 

 

0.88

 

 

0.05

12/12/2017

 

 

11/12/2018

 

 

15/09/2020

 

 

15/09/2020

12/12/2027

 

 

11/12/2028

 

 

15/09/2030

 

 

15/09/2030

Sarah Stoten

25,000

 

 

15,000

2016 EMI Scheme

 

2020 CSOP Scheme

 

0.690

 

 

0.88

11/12/2018

 

 

15/09/2020

11/12/2028

 

 

15/09/2030

 

 

(c) Interests of persons acting in concert with Franchise Brands plc (in addition to those set out in (a) above) in the ordinary shares of 0.5p each in Franchise Brands plc

 

 

Name

Number of ordinary shares held

% of voting share capital

Franchise Brands plc Employee Benefit Trust

187,717

0.20

Robin Auld

516,385

0.54

Mark Peters

1,467,045

1.53

 

Details of options held by those in 3(c) above

 

Name

Maximum number outstanding

Scheme

Exercise price (£)

Date of grant

Expiry Date

 

Robin Auld

21,970

 

 

34,091

 

2016 EMI

Scheme

 

2020 CSOP Scheme

0.69

 

 

0.88

11/12/2018

 

 

15/09/2020

11/12/2028

 

 

15/09/2030

 

(d)  Interests of connected advisers  

Name

Number of ordinary shares held

% of voting share capital

Dowgate Group Limited

70,134

0.07

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

 

 

Date of disclosure:

24 February 2022

Contact name:

Julia Choudhury

Telephone number:

+ 44 (0) 1625 813231

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEESEDFUDEESEDE
Date   Source Headline
4th Apr 20243:02 pmRNSHolding(s) in Company
20th Feb 20242:45 pmRNSCapital Markets Day
18th Jan 20247:00 amRNSCapital Markets Day
18th Jan 20247:00 amRNSTrading Update
16th Jan 20245:12 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSInvestor presentation
15th Nov 20233:11 pmRNSHolding(s) in Company
25th Oct 20237:00 amRNSQ3 Trading Update
4th Sep 20237:00 amRNSBoard and management update
4th Aug 20237:00 amRNSDirector/PDMR Shareholding and Grant of Options
27th Jul 20237:01 amRNSAppointment of Chief Financial Officer
27th Jul 20237:00 amRNSInterim Results
25th Jul 20231:51 pmRNSInvestor Presentation via Investor Meet Company
5th Jul 20237:00 amRNSNotice of Interim Results
26th Jun 20237:00 amRNSShare Purchase Programme
1st Jun 20237:00 amRNSDirector/PDMR Shareholding
18th May 202310:10 amRNSHolding(s) in Company
10th May 20235:54 pmRNSGrant of options & director holdings
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20235:00 pmRNSTotal Voting Rights
25th Apr 20234:09 pmRNSHolding(s) in Company
24th Apr 20231:55 pmRNSHolding(s) in Company
20th Apr 20239:33 amRNSResult of GM, Completion of Acquisition and TVR
18th Apr 20231:56 pmRNSResult of AGM
18th Apr 20237:00 amRNSAGM Statement and Trading Update
14th Apr 202312:10 pmRNSDirector/PDMR Shareholding
4th Apr 202312:08 pmRNSResult of Placing and Notice of GM
3rd Apr 20235:52 pmRNSProposed Acquisition and Launch of ABB
20th Mar 20237:00 amRNSPosting of Annual Report and Notice of AGM
13th Mar 202312:24 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSRule 19.6(c) confirmation
9th Mar 20234:54 pmRNSDividend Declaration and AGM date
9th Mar 20237:00 amRNSFinal Results
8th Mar 20235:20 pmRNSHolding(s) in Company
23rd Feb 20237:00 amRNSAnnual Results Presentation
22nd Feb 20237:00 amRNSAppointment of Joint Corporate Broker
25th Jan 20237:00 amRNSNotice of Results
23rd Jan 20237:00 amRNSNotice of Electronic Communications
13th Jan 20237:00 amRNSCapital Markets Day
12th Jan 20237:00 amRNSTrading Update
23rd Dec 20227:00 amRNSShare Purchase Programme
30th Nov 20225:00 pmRNSTotal Voting Rights
30th Nov 20224:40 pmRNSSecond Price Monitoring Extn
30th Nov 20224:35 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSExercise of share options, PDMR notification & TVR
1st Nov 20221:41 pmEQSFranchise Brands benefiting from strong contributions by Filta North America and Metro Rod
27th Oct 20227:00 amRNSQ3 Trading Update
3rd Oct 20227:00 amRNSAppointment of Interim CFO and grant of options
12th Sep 20227:00 amRNSAppointment of Non-Executive Director
26th Jul 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.